ArriVent BioPharma, Inc. Common Stock (AVBP) — Tangible Net Worth Ratio
ArriVent BioPharma, Inc. Common Stock (AVBP) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($366.84 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ArriVent BioPharma, Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ArriVent BioPharma, Inc. Common Stock Tangible Net Worth Ratio (2021–2025)
This chart shows how ArriVent BioPharma, Inc. Common Stock's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $366.84 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see how much is ArriVent BioPharma, Inc. Common Stock worth.
Annual Tangible Net Worth Ratio for ArriVent BioPharma, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ArriVent BioPharma, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See ArriVent BioPharma, Inc. Common Stock (AVBP) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $307.22 Million | $0.00 | $333.17 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $257.65 Million | $0.00 | $274.94 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $151.30 Million | $0.00 | $163.10 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $174.46 Million | $0.00 | $182.83 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $41.22 Million | $0.00 | $43.04 Million | — |